Contribution By Saipriya Iyer
Dunzo, an Indian online delivery platform, has reportedly unveiled a new category, Foodcourt, to enable users to place a single order of food from multiple restaurants.
Foodcourt, which will be initially available in the Koramangala neighborhood in
Trinseo has recently entered a binding agreement to acquire the PMMA (polymethyl methacrylates) and activated MMA (methyl methacrylates) businesses of Arkema.
Polymethyl methacrylates is a transparent & rigid plastic with several end-use applica
Market regulator in China has recently fined Alibaba Group, China Literature, and Shenzhen Hive Box $76,464.29 (500,000 yuan) each. This fine has been imposed on these three companies for failing to report deals to the antitrust regulators for review
As per the latest news, Maxar Technologies, SiriusXM, and Space X have reportedly announced the launch of Sirius XM’s new audio broadcasting satellite named ‘SXM-7’
SpaceX recently launched a Falcon 9 rocket from Cape Canaveral, Fl
Toray Advanced Composites, the Netherland-based multinational producer and supplier of cutting-edge composite materials, has reportedly inked a long-term supply deal with U.S-based Joby Aviation for the composite material used for its airplane.
Huntsman Corporation, a chemical manufacturing company, has recently entered an agreement to acquire a specialty chemical manufacturer, Gabriel Performance Products.
As per the terms of the recent agreement, Huntsman will make an all-cash transactio
Apex Clean Energy, a wind & solar power developer, has reportedly entered two PPAs (power purchase agreements) with McDonald’s for a total wind energy capacity of 326-MW. Under these agreements, McDonald’s will purchase 200-MW of wind
KIND, a healthy snack brand, has recently inked an agreement to acquire a wholesome and delicious snack producer, Nature’s Bakery. The takeover deal will help extend the portfolio of the businesses of Mars in the health and wellness space as we
Targovax ASA, a biotechnology company, has recently announced the demonstration of 35% ORR (objective response rate) among anti-PD1 refractory malignant melanoma patients. This significant ORR has been achieved by combining pembrolizumab (Keytruda) a